Raub Brock Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $513K | Hold |
|
|||||
|
2025
Q2 | $638K | Buy |
|
|||||
|
2025
Q1 | $632K | Hold |
|
|||||
|
2024
Q4 | $783K | Hold |
|
|||||
|
2024
Q3 | $1.08M | Hold |
|
|||||
|
2024
Q2 | $1.3M | Hold |
|
|||||
|
2024
Q1 | $1.17M | Hold |
|
|||||
|
2023
Q4 | $941K | Hold |
|
|||||
|
2023
Q3 | $828K | Hold |
|
|||||
|
2023
Q2 | $736K | Hold |
|
|||||
|
2023
Q1 | $724K | Hold |
|
|||||
|
2022
Q4 | $616K | Hold |
|
|||||
|
2022
Q3 | $453K | Hold |
|
|||||
|
2022
Q2 | $507K | Hold |
|
|||||
|
2022
Q1 | $505K | Hold |
|
|||||
|
2021
Q4 | $437K | Hold |
|
|||||
|
2021
Q3 | $437K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $307K | Hold |
|
|||||
|
2020
Q4 | $318K | Hold |
|
|||||
|
2020
Q3 | $316K | Hold |
|
|||||
|
2020
Q2 | $298K | Sell |
|
|||||
|
2020
Q1 | $300K | Hold |
|
|||||
|
2019
Q4 | $288K | Sell |
|
|||||
|
2019
Q3 | $268K | Hold |
|
|||||
|
2019
Q2 | $264K | Hold |
|
|||||
|
2019
Q1 | $271K | Hold |
|
|||||
|
2018
Q4 | $239K | Sell |
|
|||||
|
2018
Q3 | $256K | Hold |
|
|||||
|
2018
Q2 | $250K | Hold |
|
|||||
|
2018
Q1 | $267K | Sell |
|
|||||
|
2017
Q4 | $18.2M | Sell |
|
|||||
|
2017
Q3 | $17M | Buy |
|
|||||
|
2017
Q2 | $14M | Buy |
|
|||||
|
2017
Q1 | $10.7M | Buy |
|
|||||
|
2016
Q4 | $9.78M | Buy |
|
|||||
|
2016
Q3 | $10.6M | Sell |
|
|||||
|
2016
Q2 | $13.9M | Sell |
|
|||||
|
2016
Q1 | $15.4M | Buy |
|
|||||
|
2015
Q4 | $16.4M | Buy |
|
|||||
|
2015
Q3 | $15M | Sell |
|
|||||
|
2015
Q2 | $15.2M | Buy |
|
|||||
|
2015
Q1 | $14.8M | Buy |
|
|||||
|
2014
Q4 | $11.6M | Buy |
|
|||||
|
2014
Q3 | $12.9M | Sell |
|
|||||
|
2014
Q2 | $12.6M | Sell |
|
|||||
|
2014
Q1 | $12.8M | Buy |
|
|||||
|
2013
Q4 | $9.96M | Buy |
|
|||||
|
2013
Q3 | $8.81M | Buy |
|
|||||
|
2013
Q2 | $7.29M | Buy |
|